NR3C1 and Miyoshi myopathy: We then took advantage of the publicly available Affymetrix gene expression microarray data from 309 newly diagnosed MM patients to analyze NR3C1 expression in the MF, MS, CCND1 and HY groups of patients, as previously defined [18].